Incyte Stock Gaps Down On Today's Open (INCY)

NEW YORK ( TheStreet) -- Shares of Incyte (Nasdaq: INCY) were gapping down Thursday morning with an open price 18.6% lower than Wednesday's closing price. The stock closed at $24.92 Wednesday and opened today's trading at $20.29.

The average volume for Incyte has been 1.6 million shares per day over the past 30 days. Incyte has a market cap of $3.2 billion and is part of the health care sector and drugs industry. Shares are up 66% year to date as of the close of trading on Wednesday.

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs for oncology and inflammation.

TheStreet Ratings rates Incyte as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow and feeble growth in its earnings per share. You can view the full Incyte Ratings Report.

Get more investment ideas from our investment research center.
null

If you liked this article you might like

Why 2018 Will Be Better for Biotech Deals Than 2017

Why 2018 Will Be Better for Biotech Deals Than 2017

Apache, Incyte, Prudential, ON Semiconductor: 'Mad Money' Lightning Round

Apache, Incyte, Prudential, ON Semiconductor: 'Mad Money' Lightning Round

Playing Defense and Offense: Cramer's 'Mad Money' Recap (Tuesday 11/7/17)

Playing Defense and Offense: Cramer's 'Mad Money' Recap (Tuesday 11/7/17)

Who Benefits From Tax Reform?

Who Benefits From Tax Reform?

Geron Shares Rise on Fast Track Designation -- Biotech Movers

Geron Shares Rise on Fast Track Designation -- Biotech Movers